M K Proteins IPO Details

Issue Open Mar 31, 2017
Issue Close Apr 7, 2017
IPO Price ₹70
Face Value ₹10
IPO Size ₹10.23 Cr
Listing At NSE SME
IPO Lot Size 2000
  1. Protein misfolding specialist Gain nets $40m from IPO

    Fri, 19 Mar 2021 02:45:00 GMT

    the computational approach can be used to target misfolded proteins that have been considered “undruggable” using other approaches. Around $7 to $9 million from the proceeds of the IPO will be ...

  2. Re­cur­sion founders gin for­tunes as IPO back­ers show­er $436M on one of the biggest boasts in AI -- based on some very small deals

    Sat, 17 Apr 2021 09:59:00 GMT

    In the AI drug development world, boasting often comes with the territory. Yet few can rival Recursion when it comes to claiming the lead role in what company execs like to call the industrialization ...

  3. Vaccitech Confidentially Files for IPO

    Wed, 07 Apr 2021 05:38:00 GMT

    Oxford, U.K.-based Vaccitech reportedly filed confidentially in the United States for an initial public offering (IPO) on the Nasdaq.

  4. agilon health Proposes Terms For $1 Billion IPO

    Thu, 08 Apr 2021 11:27:00 GMT

    AGL has produced strong growth, is operating in a growing industry segment, and the IPO appears reasonably valued, so is worth consideration. Looking for more investing ideas like this one? Get them ...

  5. Werewolf Therapeutics looks to make a killing in the public markets with a $100M IPO

    Fri, 09 Apr 2021 05:20:00 GMT

    After banking $72 million at the start of the year, Werewolf Therapeutics now wants an IPO. The early-stage biotech is working on shape-shifting cytokine drugs, i.e., ones that deliver the promise of ...

  6. Biomea Fusion Seeks $120 Million IPO

    Mon, 12 Apr 2021 12:09:00 GMT

    Biomea Fusion has filed to raise $120 million in an IPO. The firm is developing treatments for various leukemia type cancers.

  7. Oxford vaccines spinout Vaccitech raises $168M, laying groundwork for an IPO

    Wed, 17 Mar 2021 11:20:00 GMT

    Vaccitech’s Series B round of funding was led by M&G Investment Management ... and Future Planet Capital. Oxford, U.K.-based Vaccitech spun out the of the University of Oxford in 2016 with ...

  8. Instil Bio’s upsized IPO raises $320M for clinical tests of TIL cancer cell therapy

    Fri, 19 Mar 2021 08:22:00 GMT

    Now it has $320 million more from its IPO. Instil was able to sell more shares ... compassionate use at The Christie, a Manchester, U.K.-based hospital that is the largest cancer care center ...

  9. Deliveroo CEO Shu Pins Weak IPO on Volatility, Archegos Fallout

    Wed, 14 Apr 2021 18:15:00 GMT

    Deliveroo Plc Chief Executive Officer Will Shu said that market gyrations, a rotation away from technology stocks and the blowup of investment firm Archegos Capital Management contributed to the ...

  10. UK Posts Highest IPO Quarter Since 2007

    Mon, 12 Apr 2021 12:26:00 GMT

    The U.K. closed out the first quarter of 2021 with the strongest opening for initial public offerings (IPOs) in 14 years, City A.M. reported on Monday.

  11. Exclusive: Harry’s Raises A $155 Million Series E At $1.7 Billion, A Year After The FTC Blocked Its Billion-Dollar Sale To Edgewell

    Tue, 30 Mar 2021 17:00:00 GMT

    And there's Cat Person—a high-protein cat food and pet care brand that ... to consumer businesses took off in the U.S. and the U.K. for both Harry's and Flamingo," says Raider.

  12. Germany Reassesses Astra Shot; Spain Beach Masks: Virus Update

    Tue, 30 Mar 2021 00:25:00 GMT

    Half of England Estimated to Have Antibodies (4:59 p.m. HK) More than half of the population of England was estimated to have Covid-19 antibodies in the week ended March 14, illustrating the impact of ...

M K Proteins IPO Alerts

1. M K Proteins Limited IPO - Close  Tuesday, March 28, 2017 8:52:56 PM

M K Proteins Ltd IPO to open on Mar 31, 2017 and close for subscription on Apr 07, 2017. The price band for the issue has been fixed at Rs 70. The equity shares of the issue are proposed to be listed on the SME Platform of NSE.

2. M K Proteins Limited IPO - Open  Tuesday, March 28, 2017 8:52:36 PM

M K Proteins Ltd IPO is entering in the capital markets (through NSE SME) with an initial public offering, IPO of 1,462,000 Equity Shares of Rs 10 aggregating up to Rs 10.23 Cr. The price band for the issue has been fixed at Rs 70.

M K Proteins Limited engages in manufacturing and trading of edible oils. The company offers refine rice bran, sunflower, cotton seed, soya bean, palm, canola, and rice bran bleached oils. They also provides by-products, such as rice bran fatty acid oils, rice bran waxes, gums, and spent earth; and imports and trades in edible and non-edible oils.

The issue opens on Mar 31, 2017 and closes for subscription on Apr 07, 2017. The equity shares of the issue are proposed to be listed on the SME Platform of NSE.

M K Proteins IPO News & Events FAQs

  1. 1. When M K Proteins IPO expected date?

    The M K Proteins IPO is proposed to open on Mar 31, 2017. The IPO application ends on Apr 7, 2017.

  2. 2. How to purchase M K Proteins IPO?

    Retail investors can apply in the retail or non-institutional investor category from Mar 31, 2017 to Apr 7, 2017. The M K Proteins IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

  3. 3. When M K Proteins IPO will come?

    The M K Proteins IPO will open for subscription on Mar 31, 2017. The public issue will close on Apr 7, 2017.


   I Like It. | Report Abuse

Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App